C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2004
11/16/2004	US6818243 Useful as a sweetener
11/16/2004	US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
11/16/2004	CA2344444C Co-crystallization of sugar and n-[n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl]-l-phenylalanine 1-methyl ester
11/11/2004	WO2004097406A2 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
11/11/2004	WO2004096837A1 Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same
11/11/2004	WO2004096836A1 Novel glycopeptide or peptide capable of imparting rich taste and method of imparting rich taste to food therewith
11/11/2004	WO2004096289A1 Gene introduction efficiency enhancer
11/11/2004	WO2004096212A1 Pyrazole compounds as hsp90 inhibitors for the treatment of cancer
11/11/2004	US20040225109 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/11/2004	US20040225108 Novel process for production of the somatostatin analog, octreotide
11/11/2004	US20040224901 for example, (3R)-N-[(1R)-1-[(4-Chlorophenyl)methyl]-2-[3-[cyclohexyl(5-isoxazolylcarbonyl)amino]-1-pyrrolidinyl]-2-oxoethyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide; for treating conditions responsive to the modulation of melanocortin-4 receptors such as obesity, diabetes, and sexual dysfunction
11/11/2004	US20040224900 Protease inhibitors/immunomodulator drugs; internal ribosome entry site (IRES)
11/10/2004	EP1474441A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
11/10/2004	EP1474440A2 Coniosulphides and their derivatives, method for their production and use as medicaments
11/10/2004	EP1474439A2 Dipeptides and tripeptides with anti-inflammatory activity
11/10/2004	EP1474430A1 Bi-functionalised metallocenes use for marking biological molecules
11/10/2004	EP1474423A1 Heterocyclic tripeptides as hepatitis c inhibitors
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1284990B1 Synthesis of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester by reductive alkylation and crystallization/isolation in aqueous methanol
11/10/2004	EP0986754A4 Synthetic antibiotics
11/10/2004	CN1544464A Peptides
11/10/2004	CN1544461A Uro-genital condition treatment system
11/10/2004	CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/09/2004	US6815437 Virginiamycins as bactericides; pristinamycin chemical intermediates
11/09/2004	US6815426 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/04/2004	WO2004094471A2 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/04/2004	WO2004094464A1 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants
11/04/2004	WO2004094457A2 Stable rgd peptidomimetic composition
11/04/2004	WO2004094453A2 Filtration of dipeptide and dipeptide derivative sweeteners
11/04/2004	WO2004094452A2 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
11/04/2004	WO2004093903A2 Methods and compositions for immunomodulation using cd1 antigens
11/04/2004	WO2004093798A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2004	WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004	WO2004086039A8 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220110 Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/04/2004	US20040220090 Advanced glycation end-product intermediaries and post-amadori inhibition
11/04/2004	US20040220079 Inhibitors of Memapsin 2 and use thereof
11/04/2004	US20040219631 Method for producing tripeptides and/or peptides longer than tripeptides
11/04/2004	US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004	CA2522758A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/03/2004	EP1473302A1 HETEROCYCLIC COMPOUNDS HAVING ELASTASE−INHIBITING ACTIVITY AND INTERMEDIATES THEREOF
11/03/2004	EP1472278A2 Macrocyclic peptides active against the hepatitis c virus
11/03/2004	EP1472277A1 Fap-activated anti-tumor compounds
11/03/2004	EP1472276A2 Small peptides capable of modulating the function of cd66 (ceacam) family members
11/03/2004	EP1472238A1 Bioluminescent protease assay
11/03/2004	EP1471936A2 Hiv vaccine and method of use
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP1047709B1 Compounds with growth hormone releasing properties
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1541706A Inhibitor and stimulator of stem cell proliferation and uses thereof
11/03/2004	CN1173990C Depsipeptide compound
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004	CA2317736C Bisulfate salt of hiv protease inhibitor
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
10/2004
10/28/2004	WO2004092206A1 Novel peptide, immunopotentiator and functional food and process for producing functional food
10/28/2004	WO2004092205A1 Hydroxy-substituted-20-acyloxy-camptothecin polymer derivatives and use of the same for the manufacture of a medicament
10/28/2004	WO2004092204A1 Identification of n-alkylglycine trimers for induction of apoptosis
10/28/2004	WO2004092203A2 Process for preparing macrocyclic compounds
10/28/2004	WO2004092161A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/28/2004	WO2004092133A1 Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and application thereof in the synthesis of perindopril
10/28/2004	WO2004082357A3 Novel method for the synthesis of derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid and application thereof to the synthesis of perindopril
10/28/2004	US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease
10/28/2004	US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug
10/28/2004	US20040214780 Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof
10/28/2004	US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells
10/28/2004	US20040214246 Monoclonal antibodies specific to pro-prostate specific antigen (PROPSA) for use as component of bioassy for detection of cancer
10/28/2004	US20040214184 Amino acid sequences of carcinoembryonic antigen cell adhesion molecule for use as modulaor in treatment of cell proliferative disorders; mimetics
10/28/2004	US20040213800 Active immunization to generate antibodies to soluble A-beta
10/28/2004	CA2522205A1 Process for preparing macrocyclic compounds
10/28/2004	CA2522203A1 Identification of n-alkylglycine trimers for induction of apoptosis
10/28/2004	CA2521809A1 Improved heat shock protein-based vaccines and immunotherapies
10/27/2004	EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
10/27/2004	EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004	EP0831877B1 Metabolic effects of certain glutathione analogs
10/27/2004	CN1541095A 抑制炎症的化合物 The compounds inhibit inflammation
10/27/2004	CN1172672C Alpha-ketoamide multicatalytic protease inhibitors
10/26/2004	US6809180 Compositions and methods for screening antimicrobials
10/26/2004	US6809176 Compounds for use in treatment of cancer
10/26/2004	US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors
10/26/2004	US6809075 To enhance the elasticity and/or appearance; low molecular weights; used in combination with retinoids, preferably tretinoin
10/26/2004	CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/21/2004	WO2004090103A2 Identification of novel nogo-receptors and methods related thereto
10/21/2004	WO2004089974A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction
10/21/2004	WO2004089396A2 Anti-fungal peptidomimetics
10/21/2004	WO2004089297A2 Compounds and methods for treatment of thrombosis
10/21/2004	WO2004078107A3 Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof
10/21/2004	WO2004073650A3 Peptidomimetic inhibitors of stat3 activity and their medical uses
10/21/2004	WO2003043631A3 Method for identification of tumor targeting enzymes
10/21/2004	US20040210059 Carboxylic acids, optionally in the form of amino acids, react with chloroformates to yield intermediates, which react with amines
10/21/2004	US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability
10/21/2004	US20040208884 Administering construct in conjugated or unconjugated form and in combination with immunogenic carrier to induce antibodies; anticarcinogenic agents
10/21/2004	CA2521835A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction
10/21/2004	CA2521713A1 Anti-fungal peptidomimetics
10/21/2004	CA2521469A1 Identification of novel nogo-receptors and methods related thereto
10/21/2004	CA2520763A1 Improved inhibitors for the soluble epoxide hydrolase
10/20/2004	EP1468010A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
10/20/2004	EP1468003A2 Phosphinic pseudo-peptide derivatives
10/20/2004	EP1467969A2 Dna minor groove binding compounds

1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 307